Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
vx-15 | neutral endopeptidase | NA | Clinical trial target | TTD , DGIDB | Non-Small Cell Lung Carcinoma[MeSHID:D002289] Huntington Disease[MeSHID:D006816] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Multiple Sclerosis[MeSHID:D009103] |
2.45 | phase 2 | unknown |
vx-15 | semaphorin-4d | NA | Clinical trial target | TTD , DGIDB | Non-Small Cell Lung Carcinoma[MeSHID:D002289] Huntington Disease[MeSHID:D006816] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Multiple Sclerosis[MeSHID:D009103] |
63.65 | phase 2 | unknown |
click here to return to the previous page |